Announcements

Announcements

 

Paul G. Allen Frontiers Group [to 12 Sep 2020]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 12 Sep 2020]
https://www.phe.gov/about/barda/Pages/default.aspx
BARDA News
No new digest content identified.

 

BMGF – Gates Foundation [to 12 Sep 2020]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 12 Sep 2020]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 12 Sep 2020]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 12 Sep 2020]
http://cepi.net/
Latest News
No new digest content identified.

 

EDCTP [to 12 Sep 2020]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
Latest news
No new digest content identified.

 

Emory Vaccine Center [to 12 Sep 2020]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Medicines Agency [to 12 Sep 2020]
http://www.ema.europa.eu/ema/
News & Press Releases
No new digest content identified.

 

European Vaccine Initiative [to 12 Sep 2020]
http://www.euvaccine.eu/
Latest News
No new digest content identified.

 

FDA [to 12 Sep 2020]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
September 11, 2020 – Coronavirus (COVID-19) Update: Daily Roundup September 11, 2020
In a new FDA Voices entitled, The FDA’s Scientific and Regulatory Oversight of Vaccines is Vital to Public Health, agency leaders explain that they are committed to making decisions that are guided by science and data regarding the authorization or approval of COVID-19 vaccines.
… FDA issued a temporary guidance, “Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency,” to help drug and biological product manufacturers (including animal drug manufacturers) transition from operations impacted by the COVID-19 public health emergency to normal manufacturing operations.

September 10, 2020 – Coronavirus (COVID-19) Update: Daily Roundup September 10, 2020

September 9, 2020 – Coronavirus (COVID-19) Update: Daily Roundup September 9, 2020

September 8, 2020 – Coronavirus (COVID-19) Update: Daily Roundup September 8, 2020
…The FDA has deactivated the FDA registration for 340 foreign establishments that failed to identify a U.S. Agent as required by FDA’s regulations.  Of these, 131 establishments list devices that are essential to the COVID-19 pandemic response.
…Testing updates: To date, the FDA has currently authorized 243 tests under EUAs; these include 195 molecular tests, 44 antibody tests, and 4 antigen tests.

 

Fondation Merieux [to 12 Sep 2020]
http://www.fondation-merieux.org/
News, Events
Mérieux Foundation co-organized event
ACDx Webinar focused on the critical role of diagnostics in the COVID-19 pandemic – 4 regional perspectives
September 15, 2020 – Webinar 3:00pm to 5:00pm (CET)
The COVID-19 pandemic has highlighted the major role of diagnostics in the patient’s management. Around the globe, the regions and countries have put in place different diagnostics strategies and policies to tackle this COVID-19 sanitary crisis.
The Mérieux Foundation and the London School of Hygiene & Tropical Medicine (LSHTM) are jointly organizing a 2 hour webinar on September 15 at 3pm (CET) on the critical role of diagnostics in the COVID-19 crisis management to share best practices & lessons learnt from experiences around the world.

 

Gavi [to 12 Sep 2020]
https://www.gavi.org/
News releases
No new digest content identified.

 

GHIT Fund [to 12 Sep 2020]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that No new digest content identified.

 

Global Fund [to 12 Sep 2020]
https://www.theglobalfund.org/en/news/
News/Updates
COVID-19 Response: Corticosteroids
08 September 2020
Following the World Health Organization guidance Corticosteroids for COVID-19 from 2 September, the Global Fund has confirmed that corticosteroids can be funded through Global Fund grants.

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 12 Sep 2020]
https://www.glopid-r.org/news/
News
Mérieux Foundation seeks Scientific and Advocacy Director for the GloPID-R Secretariat
01/09/2020
Since 2015, the GloPID-R alliance has been pursuing its objectives to increase preparedness and facilitate rapid research response to outbreaks…

 

Hilleman Laboratories [to 12 Sep 2020]
http://www.hillemanlabs.org/
No new digest content identified.

 

Human Vaccines Project [to 12 Sep 2020]
http://www.humanvaccinesproject.org/media/press-releases/
Press Release
No new digest content identified.

 

IAVI [to 12 Sep 2020]
https://www.iavi.org/newsroom
FEATURES
September 8, 2020
IAVI Researchers Publish Study on Antibody Responses to HIV Immunogen in Non-human Primates
Researchers at IAVI’s Neutralizing Antibody Center (NAC), Scripps Research, and other partner organizations have identified and isolated a suite of neutralizing HIV antibodies that develop in rhesus macaques in response to immunization with BG505 SOSIP. This immunogen is the basis of several HIV vaccine candidates now in Phase I clinical trials, including the IAVI W001 trial. Their findings were published in Cell Reports on September 8, 2020…

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Announcements
No new digest content identified.

 

IFRC [to 12 Sep 2020]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Europe, Greece
Residents of Moria camp must be moved now – Red Cross head
Around 13,000 people are lacking food, water and shelter, after devastating fires on Tuesday and Wednesday this week. At the time of the first fire the camp was under lockdown due to more than 30 COVID19 positive cases.
11 September 2020

Africa, Sudan
Red Cross launches Emergency Appeal for Sudan as deadly flooding leaves thousands homeless
Nairobi/Geneva, 11 September 2020 — The International Federation of Red Cross and Red Crescent Societies (IFRC) today launched an additional funds appeal for 12 million Swiss Francs to support the Sudanese Red Crescent Society (SRCS) in delivering assi …
11 September 2020

Global
Red Cross Red Crescent turns to Rakuten Viber to fight COVID-19 infodemic
Geneva, 10 September 2020 – The International Federation of Red Cross and Red Crescent Societies (IFRC) and the Croatian Red Cross today signed a new partnership agreement with global messaging app Rakuten Viber to engage new online audiences with trus …
10 September 2020

Global
Migrants and refugees “least protected, most affected” in COVID crisis, warns IFRC President
Geneva, 10 September 2020 – The COVID-19 pandemic has been a disaster for people from all walks of life, but an absolute “catastrophe” for the world’s vulnerable migrants, people seeking asylum and refugees. Already weak social safety nets are eroding, …
10 September 2020

Global
IFRC’s first ever virtual climate summit, Climate:Red, is happening everywhere on 9-10 September 
Geneva, 8 September 2020 – Climate:Red, a fully virtual and truly global climate change summit, is bringing youth champions, activists, indigenous leaders, scientists and government ministers together on 9 – 10 September 2020 for 30 hours of innovation …
8 September 2020

 

IRC International Rescue Committee [to 12 Sep 2020]
http://www.rescue.org/press-release-index
Media highlights {Selected]
Press Release
As the threat of resettlement postponement looms, IRC urges the Trump Administration to set refugee admissions cap to at least 95,000 by September 30
September 11, 2020

Press Release
International Rescue Committee’s Pakistan Reading Project Wins 2020 International Prize from the Library of Congress
September 10, 2020

Statement
New UN report details ongoing atrocities in Yemen; IRC calls for immediate ceasefire
September 10, 2020

Press Release
New Research Finds Lack of Access to Adequate Child Care As One of the Top Barriers to Economic Empowerment for Refugee Women
September 10, 2020

Press Release
Over 12,000 people left stranded in Lesvos after a fire engulfs Moria reception centre; IRC providing mental health support to survivors
September 9, 2020

 

IVAC [to 12 Sep 2020]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
Webinar: Avoiding Barriers to Access for a COVID-19 Vaccine
Register: The International Vaccine Access Center (IVAC) on September 16, 2020 at 8:00 EDT/21:00 KST will host a 60-minute webinar, “Avoiding Barriers to Access for a COVID-19 Vaccine.”
Description: Even before the COVID-19 pandemic, countries worked to overcome a myriad of challenges when introducing new safe and effective vaccines. While policy makers and health advocates addressed barriers, from understanding disease burden and cost effectiveness to establishing cold chain systems, preventable diseases spread, sicken populations, and cost lives. Learning from the past failures of vaccine introductions will be crucial for ensuring equitable access to a COVID-19 vaccine. Leaders and scientists in the international vaccine field will discuss the barriers to vaccine access we must overcome to avoid and the role the international community will play in promoting equity in delivering a COVID-19 vaccine.

 

IVI [to 12 Sep 2020]
http://www.ivi.int/
Selected IVI News & Announcements
IVI to ready clinical trial sites for COVID-19 vaccine efficacy trials in 4 countries
September 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded close to 1.5 million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials.
[See COVID-19 above for detail]

 

JEE Alliance [to 12 Sep 2020]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 12 Sep 2020]
http://www.msf.org/
Latest [Selected Announcements]
Myanmar
MSF hands over long-running HIV project in Yangon to ministry of …
Project Update 10 Sep 2020

Greece
All people in Moria camp must be evacuated to safety in wake of destru…
Project Update 9 Sep 2020

Pakistan
Meeting regular health needs amid the COVID-19 pandemic in…
Project Update 8 Sep 2020

 

 

Nigeria
“Children can draw assault rifles better than a football” in Borno state
Interview 8 Sep 2020

 

National Vaccine Program Office – U.S. HHS [to 12 Sep 2020]
https://www.hhs.gov/vaccines/about/index.html
NVAC Meetings
September 23-24, 2020 Meeting (Virtual)
Selected Agenda Topics:
:: Serving Up Equity: Health-In-All Approaches for COVID-19 Vaccination [Panel]
:: Allocation and Prioritization: Considerations and Recommendations for the Distribution of
COVID-19 Vaccines [Dr. Ezekiel Emanuel, University of Pennsylvania; CDC tbd]
:: Perspectives from the Field: Operation Warp Speed [Dr. Moncef Slaoui, HHS]
:: The Infodemic, COVID-19 Immunization, and the Public’s Health [Panel]
:: Immunization Information Systems to Support the COVID-19 Response [Panel]

 

NIH [to 12 Sep 2020]
http://www.nih.gov/news-events/news-releases
Selected News Releases
NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19
September 10, 2020
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings — those who have not been hospitalized, those currently hospitalized and those discharged after hospitalization for moderate to severe disease.
Collectively known as ACTIV-4 Antithrombotics, the trials will provide critical insights that could help guide the care of patients with COVID-19, particularly those who suffer from life-threatening blood clots. The trial for hospitalized COVID-19 patients and the trial for patients with COVID-19 who have not been hospitalized are now underway. A third trial to start later will focus on patients discharged after hospitalization for moderate to severe COVID-19 disease. All three clinical trials will be coordinated and overseen by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, and funded through Operation Warp Speed(link is external)

 

PATH [to 12 Sep 2020]
https://www.path.org/media-center/
Press Releases
No new digest content identified.

 

Sabin Vaccine Institute [to 12 Sep 2020]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 12 Sep 2020]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
9 September 2020
Cash donations for people who use drugs during COVID-19 in Bangladesh

 

UNICEF [to 12 Sep 2020]
https://www.unicef.org/media/press-releases
Selected Press releases/Announcements
Statement
09/11/2020
UNICEF statement on children affected by the Moria camp fire on Lesvos Island, Greece

Statement
09/11/2020
Polio programme accelerates efforts to respond to new polio outbreaks in Sudan and Yemen
Joint statement by WHO Regional Director for the Eastern Mediterranean Region Dr Ahmed Al Mandhari and UNICEF Regional Director for the Middle East and North Africa Region Ted Chaiban

Statement
09/10/2020
UNICEF Executive Director Henrietta Fore’s remarks at the UN Security Council Open Debate on Children and Armed Conflict: Attacks against schools as a grave violation of children’s rights
This is a summary of what was said by Henrietta Fore, UNICEF Executive Director – to whom quoted text may be attributed – at today’s Security Council Open Debate at the United Nations in New York. Checked against delivery.

Press release
09/10/2020
The Time to Prepare for COVID-19 Vaccine Transport is Now
[See COVID-19 above for detail]

Statement
09/10/2020
Remarks by UNICEF Executive Director Henrietta Fore at the 2020 Executive Board Session

Press release
09/09/2020
More than half a million children under five in Burkina Faso are acutely malnourished – UNICEF

Statement
09/09/2020
UNICEF statement on fire at Moria Camp in Lesvos, Greece

Press release
09/08/2020
COVID-19 could reverse decades of progress toward eliminating preventable child deaths, agencies warn
With the number of under-five deaths at an all-time recorded low of 5.2 million in 2019, disruptions in child and maternal health services due to the COVID-19 pandemic are putting millions of additional lives at stake

 

Unitaid [to 12 Sep 2020]
https://unitaid.org/
Featured News
No new digest content identified.

 

Vaccination Acceptance Research Network (VARN) [to 12 Sep 2020]
https://vaccineacceptance.org/news.html#header1-2r
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 12 Sep 2020]
http://www.vaccineconfidence.org/
Research and Reports
No new digest content identified.

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 12 Sep 2020]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

 

Wellcome Trust [to 12 Sep 2020]
https://wellcome.ac.uk/news
Explainer | 11 September 2020
Safety first: how to run a Covid-19 vaccine clinical trial
The world is waiting eagerly for Covid-19 vaccines to be developed as quickly as possible. But to make sure they are safe and effective, the clinical trials that test them have to be robust. So how do trials achieve this?

Opinion | 7 September 2020
The first Covid-19 vaccine may not be the magic bullet that returns life to ‘normal’
Jeremy Farrar
Director Wellcome
As we’ll soon start to see the results of the first vaccines coming through late-stage clinical trials, Jeremy Farrar explains why we should be cautiously optimistic.

 

The Wistar Institute [to 12 Sep 2020]
https://www.wistar.org/news/press-releases
Press Releases
Sep. 10, 2020
Scientists Engineer DNA-based Nanotechnology to Stimulate Potent Antitumor Immune Responses in Preclinical Models
Synthetic DNA nanovaccines enhance killer T cell immunity resulting in tumor control in preclinical studies.

Press Release
Sep. 7, 2020
The BEAT-HIV Martin Delaney Collaboratory Issues Recommendations on Measuring Persistent HIV Reservoirs in Cure-directed Clinical Trials
The consortium provides first authoritative viewpoint on which viral measurements to prioritize when evaluating the impact of potential therapeutic strategies to eradicate HIV.

 

WFPHA: World Federation of Public Health Associations [to 12 Sep 2020]
https://www.wfpha.org/
Latest News
No new digest content identified.

 

World Organisation for Animal Health (OIE) [to 12 Sep 2020]
https://www.oie.int/en/for-the-media/press-releases/2020/
Press Releases
No new digest content identified.

 

 

::::::

 

ARM [Alliance for Regenerative Medicine] [to 12 Sep 2020]
https://alliancerm.org/press-releases/
Press Releases
No new digest content identified.

 

BIO [to 12 Sep 2020]
https://www.bio.org/press-releases
Press Releases
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 12 Sep 2020]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 12 Sep 2020]
https://internationalbiotech.org/
News
No new digest content identified.

 

IFPMA [to 12 Sep 2020]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
COVID-19 Vaccine Maker Pledge
08 September 2020
[See COVID-19 Vaccines above for detail]

 

PhRMA [to 12 Sep 2020]
http://www.phrma.org/
Selected Press Releases, Statements
PhRMA member companies invested $83 billion in research and development last year
Tim McClung   |     September 10, 2020   |
PhRMA member companies invested $83 billion in research and development (R&D) in 2019, the highest level of investment on record, according to the 2020 PhRMA member annual survey. Over the past two decades, PhRMA member companies have invested a grand total of nearly $1 trillion in the search for and development of new and better treatments and cures.
America’s biopharmaceutical companies are at the heart of a robust R&D ecosystem that develops more innovative medicines than any other country in the world. There are nearly 260 vaccines in development for the treatment or prevention of disease, including numerous different types of potential vaccines that target COVID-19…